MetaADEDB 2.0 @ LMMD
Moxifloxacin
(IDIIJJHBXUESQI-DFIJPDEKSA-N)
Structure
SMILES
COc1c(N2C[C@@H]3[C@H](C2)CCCN3)c(F)cc2c1n(cc(c2=O)C(=O)O)C1CC1.Cl
Molecular Formula:
C21H25ClFN3O4
Molecular Weight:
437.892
Log P:
3.5663
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
83.8
CAS Number(s):
186826-86-8; 192927-63-2
Synonym(s)
1.
Moxifloxacin
2.
1-Cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
3.
Actira
4.
Avalox
5.
Avelox
6.
BAY 12-8039
7.
BAY 128039
8.
BAY-12-8039
9.
BAY-128039
10.
Izilox
11.
Moxifloxacin Hydrochloride
12.
Octegra
13.
Proflox
14.
BAY 12 8039
15.
BAY128039
External Link(s)
MeSHD000077266
PubChem Compound138753053
101526
ChEBI7008
CHEMBLCHEMBL1200735
KEGGdr:D00874
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypersensitivityFAERS: 757
Canada Vigilance: 18
Canada Vigilance
US FAERS
2DizzinessFAERS: 750
Canada Vigilance: 44
Canada Vigilance
US FAERS
3UrticariaFAERS: 586
Canada Vigilance: 20
Canada Vigilance
US FAERS
4NauseaFAERS: 583
Canada Vigilance: 38
Canada Vigilance
US FAERS
5PruritusFAERS: 518
Canada Vigilance: 20
Canada Vigilance
US FAERS
6VomitingFAERS: 376
Canada Vigilance: 15
Canada Vigilance
US FAERS
7ArthralgiaFAERS: 375
Canada Vigilance: 27
Canada Vigilance
US FAERS
8AnxietyFAERS: 346
Canada Vigilance: 22
Canada Vigilance
US FAERS
9ErythemaFAERS: 308
Canada Vigilance: 14
Canada Vigilance
US FAERS
10PainFAERS: 300
Canada Vigilance: 10
Canada Vigilance
US FAERS
11HeadacheFAERS: 284
Canada Vigilance: 24
Canada Vigilance
US FAERS
12Anaphylactic shockFAERS: 279
Canada Vigilance: 10
Canada Vigilance
US FAERS
13TremorFAERS: 267
Canada Vigilance: 24
Canada Vigilance
US FAERS
14PalpitationsFAERS: 250
Canada Vigilance: 15
Canada Vigilance
US FAERS
15AstheniaFAERS: 242
Canada Vigilance: 14
Canada Vigilance
US FAERS
16MyalgiaFAERS: 211
Canada Vigilance: 17
Canada Vigilance
US FAERS
17Feeling abnormalFAERS: 210
Canada Vigilance: 4
Canada Vigilance
US FAERS
18HypotensionFAERS: 187
Canada Vigilance: 7
Canada Vigilance
US FAERS
19FatigueFAERS: 160
Canada Vigilance: 14
Canada Vigilance
US FAERS
20Burning sensationFAERS: 153
Canada Vigilance: 6
Canada Vigilance
US FAERS
21Lip swellingFAERS: 152
Canada Vigilance: 9
Canada Vigilance
US FAERS
22MalaiseFAERS: 145
Canada Vigilance: 10
Canada Vigilance
US FAERS
23Chest PainFAERS: 144
Canada Vigilance: 6
Canada Vigilance
US FAERS
24Chest discomfortFAERS: 144
Canada Vigilance: 7
Canada Vigilance
US FAERS
25SyncopeFAERS: 139
Canada Vigilance: 5
Canada Vigilance
US FAERS
26TachycardiaFAERS: 138
Canada Vigilance: 12
Canada Vigilance
US FAERS
27NervousnessFAERS: 124
Canada Vigilance: 3
Canada Vigilance
US FAERS
28SwellingFAERS: 120
Canada Vigilance: 5
Canada Vigilance
US FAERS
29Abdominal PainFAERS: 107
Canada Vigilance: 8
Canada Vigilance
US FAERS
30Visual ImpairmentFAERS: 104
Canada Vigilance: 12
Canada Vigilance
US FAERS
31FlushingFAERS: 102
Canada Vigilance: 4
Canada Vigilance
US FAERS
32ChillsFAERS: 101
Canada Vigilance: 3
Canada Vigilance
US FAERS
33Adverse eventFAERS: 97
Canada Vigilance: 2
Canada Vigilance
US FAERS
34nervous system disorderFAERS: 93
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Abdominal discomfortFAERS: 91
Canada Vigilance: 14
Canada Vigilance
US FAERS
36Joint swellingFAERS: 85
Canada Vigilance: 2
Canada Vigilance
US FAERS
37UveitisFAERS: 82
Canada Vigilance: 1
Canada Vigilance
US FAERS
38DisorientationFAERS: 79
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Unevaluable eventFAERS: 79US FAERS
40Clostridium difficile colitisFAERS: 76
Canada Vigilance: 5
Canada Vigilance
US FAERS
41Emotional distressFAERS: 76
Canada Vigilance: 2
Canada Vigilance
US FAERS
42Back PainFAERS: 75
Canada Vigilance: 6
Canada Vigilance
US FAERS
43AngioedemaFAERS: 74
Canada Vigilance: 2
Canada Vigilance
US FAERS
44AbasiaFAERS: 70US FAERS
45Rash erythematousFAERS: 68
Canada Vigilance: 5
Canada Vigilance
US FAERS
46AgitationFAERS: 67
Canada Vigilance: 4
Canada Vigilance
US FAERS
47PhotophobiaFAERS: 67
Canada Vigilance: 2
Canada Vigilance
US FAERS
48PneumoniaFAERS: 67
Canada Vigilance: 1
Canada Vigilance
US FAERS
49TinnitusFAERS: 65
Canada Vigilance: 5
Canada Vigilance
US FAERS
50Musculoskeletal PainFAERS: 64
Canada Vigilance: 1
Canada Vigilance
US FAERS
51No adverse eventFAERS: 64US FAERS
52DysgeusiaFAERS: 62
Canada Vigilance: 2
Canada Vigilance
US FAERS
53Stevens-Johnson SyndromeFAERS: 62
Canada Vigilance: 2
Canada Vigilance
US FAERS
54Eye painFAERS: 61
Canada Vigilance: 3
Canada Vigilance
US FAERS
55VertigoFAERS: 59
Canada Vigilance: 7
Canada Vigilance
US FAERS
56RestlessnessFAERS: 56US FAERS
57SomnolenceFAERS: 56US FAERS
58Drug ineffectiveFAERS: 55
Canada Vigilance: 6
Canada Vigilance
US FAERS
59DeliriumFAERS: 54
Canada Vigilance: 2
Canada Vigilance
US FAERS
60Cardiac ArrestFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
61DehydrationFAERS: 53US FAERS
62jaundiceFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
63AgeusiaFAERS: 52
Canada Vigilance: 6
Canada Vigilance
US FAERS
64AphasiaFAERS: 52
Canada Vigilance: 1
Canada Vigilance
US FAERS
65WheezingFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
66AnosmiaFAERS: 48
Canada Vigilance: 6
Canada Vigilance
US FAERS
67Neck PainFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
68AmnesiaFAERS: 44
Canada Vigilance: 4
Canada Vigilance
US FAERS
69Impaired work abilityFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
70SinusitisFAERS: 43US FAERS
71IridocyclitisFAERS: 42US FAERS
72MydriasisFAERS: 42US FAERS
73Eye irritationFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
74Feeling jitteryFAERS: 41US FAERS
75BlindnessFAERS: 40US FAERS
76Musculoskeletal stiffnessFAERS: 40
Canada Vigilance: 2
Canada Vigilance
US FAERS
77Respiratory distressFAERS: 39
Canada Vigilance: 2
Canada Vigilance
US FAERS
78DiplopiaFAERS: 37
Canada Vigilance: 3
Canada Vigilance
US FAERS
79Atrial FibrillationFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Depressed Level of ConsciousnessFAERS: 36US FAERS
81DiscomfortFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Iris transillumination defectFAERS: 36US FAERS
83PresyncopeFAERS: 36
Canada Vigilance: 4
Canada Vigilance
US FAERS
84LethargyFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Respiratory arrestFAERS: 35US FAERS
86ShockFAERS: 35US FAERS
87ThrombocytopeniaFAERS: 35
Canada Vigilance: 3
Canada Vigilance
US FAERS
88Weight decreasedFAERS: 35
Canada Vigilance: 8
Canada Vigilance
US FAERS
89Infusion site erythemaFAERS: 34US FAERS
90CyanosisFAERS: 33US FAERS
91Memory impairmentFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
92Myocardial InfarctionFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
93ParanoiaFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
94DeafnessFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
95Cold sweatFAERS: 30
Canada Vigilance: 4
Canada Vigilance
US FAERS
96CryingFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
97HepatotoxicityFAERS: 30US FAERS
98InflammationFAERS: 30US FAERS
99ArthropathyFAERS: 29US FAERS
100Oropharyngeal painFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
101PallorFAERS: 29US FAERS
102RhabdomyolysisFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
103DyspepsiaFAERS: 28
Canada Vigilance: 3
Canada Vigilance
US FAERS
104Feeling ColdFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
105Mental status changesFAERS: 28US FAERS
106Quality of life decreasedFAERS: 28US FAERS
107Activities of daily living impairedFAERS: 27US FAERS
108Alanine Aminotransferase IncreasedFAERS: 27
Canada Vigilance: 5
Canada Vigilance
US FAERS
109Skin reactionFAERS: 27US FAERS
110BronchitisFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
111Aspartate Aminotransferase IncreasedFAERS: 25
Canada Vigilance: 6
Canada Vigilance
US FAERS
112BradycardiaFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Infusion site reactionFAERS: 25US FAERS
114Joint stiffnessFAERS: 25US FAERS
115Muscle tightnessFAERS: 25US FAERS
116FormicationFAERS: 24US FAERS
117Impaired driving abilityFAERS: 24US FAERS
118Injection site irritationFAERS: 24US FAERS
119Mental impairmentFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
120AnhedoniaFAERS: 23US FAERS
121AnorexiaFAERS: 23US FAERS
122ChromaturiaFAERS: 23
Canada Vigilance: 6
Canada Vigilance
US FAERS
123NeuralgiaFAERS: 23US FAERS
124SepsisFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Serum SicknessFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
126Toxic Epidermal NecrolysisFAERS: 22US FAERS
127Vessel puncture site reactionFAERS: 22US FAERS
128Respiratory FailureFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
129Rotator cuff syndromeFAERS: 21US FAERS
130Visual disturbanceFAERS: 21US FAERS
131General physical health deteriorationFAERS: 20US FAERS
132HepatitisFAERS: 20
Canada Vigilance: 4
Canada Vigilance
US FAERS
133IncoherentFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
134Throat irritationFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Urinary IncontinenceFAERS: 20US FAERS
136DysphoniaFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Ear discomfortFAERS: 19US FAERS
138Emotional disorderFAERS: 19US FAERS
139FlatulenceFAERS: 19US FAERS
140InfectionFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
141Injection Site ReactionFAERS: 19US FAERS
142Injection site erythemaFAERS: 19US FAERS
143Bone painFAERS: 18US FAERS
144Depressed moodFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
145DysarthriaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Infusion site rashFAERS: 18US FAERS
147Urinary tract infectionFAERS: 18US FAERS
148AlopeciaFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
149BronchospasmFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
150PancreatitisFAERS: 17US FAERS
151Blood creatine phosphokinase increasedFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
152Blood glucose decreasedFAERS: 16US FAERS
153ColitisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
154EndophthalmitisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
155Myasthenia GravisFAERS: 16US FAERS
156Night sweatsFAERS: 16US FAERS
157Altered state of consciousnessFAERS: 15US FAERS
158ArthritisFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
159CandidiasisFAERS: 15US FAERS
160Cerebrovascular accidentFAERS: 15US FAERS
161DysuriaFAERS: 15US FAERS
162Eye InfectionFAERS: 15US FAERS
163GlaucomaFAERS: 15US FAERS
164Infusion site pruritusFAERS: 15US FAERS
165PetechiaeFAERS: 15US FAERS
166Vitreous floatersFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Anaphylactoid ReactionFAERS: 14US FAERS
168AsthmaFAERS: 14US FAERS
169Blood glucose increasedFAERS: 14US FAERS
170Blood urine presentFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
171Drug toxicityFAERS: 14US FAERS
172LymphadenopathyFAERS: 14US FAERS
173Product quality issueFAERS: 14US FAERS
174Ventricular FibrillationFAERS: 14US FAERS
175Angina PectorisFAERS: 13US FAERS
176Middle insomniaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Pain of skinFAERS: 13US FAERS
178Skin lesionFAERS: 13US FAERS
179ThirstFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
180BedriddenFAERS: 12US FAERS
181HypoxiaFAERS: 12US FAERS
182LeukopeniaFAERS: 12US FAERS
183Nerve injuryFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
184Ocular icterusFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
185Retinal DetachmentFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
186AphagiaFAERS: 11US FAERS
187Blood potassium decreasedFAERS: 11US FAERS
188Blood pressure immeasurableFAERS: 11US FAERS
189CholestasisFAERS: 11US FAERS
190ConjunctivitisFAERS: 11US FAERS
191EosinophiliaFAERS: 11US FAERS
192Erythema MultiformeFAERS: 11US FAERS
193HyperventilationFAERS: 11US FAERS
194Hypoaesthesia facialFAERS: 11US FAERS
195Palmar erythemaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
196RetchingFAERS: 11US FAERS
197Troponin increasedFAERS: 11US FAERS
198Unresponsive to stimuliFAERS: 11US FAERS
199Urinary RetentionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
200GlossitisFAERS: 10US FAERS
201Infusion Site ExtravasationFAERS: 10US FAERS
202Initial insomniaFAERS: 10US FAERS
203IritisFAERS: 10US FAERS
204Limb discomfortFAERS: 10US FAERS
205Lipase increasedFAERS: 10US FAERS
206PhlebitisFAERS: 10US FAERS
207Physical disabilityFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
208Poor quality drug administeredFAERS: 10US FAERS
209Pulmonary EmbolismFAERS: 10US FAERS
210Renal painFAERS: 10US FAERS
211Skin UlcerFAERS: 10US FAERS
212Transaminases increasedFAERS: 10US FAERS
213VasculitisFAERS: 10US FAERS
214muscle injuryFAERS: 10US FAERS
215pseudomembranous colitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
216AngerFAERS: 9US FAERS
217Auricular swellingFAERS: 9US FAERS
218Blood alkaline phosphatase increasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
219Blood creatinine increasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
220Choking sensationFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
221DisabilityFAERS: 9US FAERS
222DysphemiaFAERS: 9US FAERS
223ExtravasationFAERS: 9US FAERS
224Eye inflammationFAERS: 9US FAERS
225Gamma-Glutamyltransferase IncreasedFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
226Pharmaceutical product complaintFAERS: 9US FAERS
227Product use in unapproved indicationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
228Retinal depigmentationFAERS: 9US FAERS
229Septic ShockFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
230StomatitisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
231Sudden deathFAERS: 9US FAERS
232SunburnFAERS: 9US FAERS
233Therapeutic response unexpectedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
234ThrombosisFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
235Acute respiratory failureFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
236Clostridium colitisFAERS: 8US FAERS
237ConstipationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
238DementiaFAERS: 8US FAERS
239Economic problemFAERS: 8US FAERS
240EmpyemaFAERS: 8US FAERS
241EpistaxisFAERS: 8US FAERS
242Head discomfortFAERS: 8US FAERS
243Injection site extravasationFAERS: 8US FAERS
244Musculoskeletal discomfortFAERS: 8US FAERS
245MyositisFAERS: 8US FAERS
246NeutropeniaFAERS: 8US FAERS
247Oral pruritusFAERS: 8US FAERS
248OverdoseFAERS: 8US FAERS
249PancytopeniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
250Peripheral swellingFAERS: 8
Canada Vigilance: 5
Canada Vigilance
US FAERS
251Rheumatoid ArthritisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
252SneezingFAERS: 8US FAERS
253StuporFAERS: 8US FAERS
254Supraventricular tachycardiaFAERS: 8US FAERS
255Temperature intoleranceFAERS: 8US FAERS
256Therapy non-responderFAERS: 8US FAERS
257Tongue blisteringFAERS: 8US FAERS
258AnuriaFAERS: 7US FAERS
259Atrioventricular BlockFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
260Carpal Tunnel SyndromeFAERS: 7US FAERS
261CataractFAERS: 7US FAERS
262Drug exposure during pregnancyFAERS: 7US FAERS
263Dry skinFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Electrocardiogram abnormalFAERS: 7US FAERS
265EncephalitisFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
266EpilepsyFAERS: 7US FAERS
267Foaming at mouthFAERS: 7US FAERS
268Foreign body sensation in eyesFAERS: 7US FAERS
269GastroenteritisFAERS: 7US FAERS
270Grip strength decreasedFAERS: 7US FAERS
271HypopyonFAERS: 7US FAERS
272Injection site pruritusFAERS: 7US FAERS
273Joint Range of Motion DecreasedFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
274Mood swingsFAERS: 7US FAERS
275Muscle strainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
276NeuropathyFAERS: 7US FAERS
277Oral painFAERS: 7US FAERS
278PolyuriaFAERS: 7US FAERS
279Sinus TachycardiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
280Skin irritationFAERS: 7US FAERS
281Suicide attemptFAERS: 7US FAERS
282White blood cell count decreasedFAERS: 7US FAERS
283Anterior chamber inflammationFAERS: 6US FAERS
284Aphthous StomatitisFAERS: 6US FAERS
285BlepharospasmFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
286Bowel movement irregularityFAERS: 6US FAERS
287CheilitisFAERS: 6US FAERS
288DystoniaFAERS: 6US FAERS
289Facial PainFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
290Gastrointestinal PainFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
291HypersomniaFAERS: 6US FAERS
292HypophagiaFAERS: 6US FAERS
293InfluenzaFAERS: 6US FAERS
294Infusion site irritationFAERS: 6US FAERS
295KeratitisFAERS: 6US FAERS
296Ligament ruptureFAERS: 6US FAERS
297Medication ErrorFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
298MeningitisFAERS: 6US FAERS
299Metabolic acidosisFAERS: 6US FAERS
300MetamorphopsiaFAERS: 6US FAERS
301NephrolithiasisFAERS: 6US FAERS
302Ocular discomfortFAERS: 6US FAERS
303Oropharyngeal blisteringFAERS: 6US FAERS
304Oropharyngeal discomfortFAERS: 6US FAERS
305PoisoningFAERS: 6US FAERS
306PolyarthritisFAERS: 6US FAERS
307Respiratory DepressionFAERS: 6US FAERS
308Restless Legs SyndromeFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
309StressFAERS: 6US FAERS
310Thermal burnFAERS: 6US FAERS
311Vessel puncture site swellingFAERS: 6US FAERS
312VitritisFAERS: 6US FAERS
313Wrong technique in drug usage processFAERS: 6US FAERS
314AcneFAERS: 5US FAERS
315Altered visual depth perceptionFAERS: 5US FAERS
316Aortic AneurysmFAERS: 5US FAERS
317AsphyxiaFAERS: 5US FAERS
318Blood sodium decreasedFAERS: 5US FAERS
319Cardiac discomfortFAERS: 5US FAERS
320CellulitisFAERS: 5US FAERS
321ChromatopsiaFAERS: 5US FAERS
322Completed SuicideFAERS: 5US FAERS
323DissociationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
324Documented hypersensitivity to administered drugFAERS: 5US FAERS
325Drug dispensing errorFAERS: 5US FAERS
326DysgraphiaFAERS: 5US FAERS
327Escherichia infectionFAERS: 5US FAERS
328Euphoric moodFAERS: 5US FAERS
329GoutFAERS: 5US FAERS
330HyperacusisFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
331HyperthyroidismFAERS: 5US FAERS
332HypogeusiaFAERS: 5US FAERS
333HypokinesiaFAERS: 5US FAERS
334Intraocular pressure testFAERS: 5US FAERS
335Irritable Bowel SyndromeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
336LacerationFAERS: 5US FAERS
337Leukocytoclastic vasculitisFAERS: 5US FAERS
338LeukocytosisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
339Lobar PneumoniaFAERS: 5US FAERS
340Lymphocyte stimulation test positiveFAERS: 5US FAERS
341MyoclonusFAERS: 5US FAERS
342NasopharyngitisFAERS: 5US FAERS
343OliguriaFAERS: 5US FAERS
344Oral candidiasisFAERS: 5US FAERS
345Panic DisorderFAERS: 5US FAERS
346Pharyngolaryngeal PainFAERS: 5US FAERS
347PleurisyFAERS: 5US FAERS
348PneumonitisFAERS: 5US FAERS
349PolyneuropathyFAERS: 5US FAERS
350Poor quality sleepFAERS: 5US FAERS
351Product use issueFAERS: 5US FAERS
352Psychiatric symptomFAERS: 5US FAERS
353Renal tubular necrosisFAERS: 5US FAERS
354Sinus headacheFAERS: 5US FAERS
355StridorFAERS: 5US FAERS
356Sudden Cardiac DeathFAERS: 5US FAERS
357Suspected counterfeit productFAERS: 5US FAERS
358Temperature regulation disorderFAERS: 5US FAERS
359TensionFAERS: 5US FAERS
360Toxicity to various agentsFAERS: 5US FAERS
361Acute myocardial infarctionFAERS: 4US FAERS
362AgranulocytosisFAERS: 4US FAERS
363AlbinismFAERS: 4US FAERS
364Ammonia increasedFAERS: 4US FAERS
365Apparent deathFAERS: 4US FAERS
366Blood lactate dehydrogenase increasedFAERS: 4US FAERS
367Blood pressure fluctuationFAERS: 4US FAERS
368Blood pressure orthostatic abnormalFAERS: 4US FAERS
369CatatoniaFAERS: 4US FAERS
370Cerebral InfarctionFAERS: 4US FAERS
371Corneal erosionFAERS: 4US FAERS
372Deafness NeurosensoryFAERS: 4US FAERS
373DermatitisFAERS: 4US FAERS
374Diabetes MellitusFAERS: 4US FAERS
375DiplegiaFAERS: 4US FAERS
376Drug use for unknown indicationFAERS: 4US FAERS
377Electrocardiogram ST segment abnormalFAERS: 4US FAERS
378GangreneFAERS: 4US FAERS
379GastritisFAERS: 4US FAERS
380Hallucinations, mixedFAERS: 4US FAERS
381Hypertensive crisisFAERS: 4US FAERS
382HypoventilationFAERS: 4US FAERS
383Infusion site phlebitisFAERS: 4US FAERS
384Intraocular pressure test abnormalFAERS: 4US FAERS
385Lichen PlanusFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
386Mastication disorderFAERS: 4US FAERS
387MenorrhagiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
388MonoplegiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
389Multiple SclerosisFAERS: 4US FAERS
390Muscle RigidityFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
391Oropharyngeal swellingFAERS: 4US FAERS
392Pelvic PainFAERS: 4US FAERS
393Pharyngolaryngeal discomfortFAERS: 4US FAERS
394Pre-existing condition improvedFAERS: 4US FAERS
395Product dropper issueFAERS: 4US FAERS
396Product packaging issueFAERS: 4US FAERS
397Product taste abnormalFAERS: 4US FAERS
398Prostatic painFAERS: 4US FAERS
399Pupillary deformityFAERS: 4US FAERS
400QuadriparesisFAERS: 4US FAERS
401Rectal dischargeFAERS: 4US FAERS
402SchizophreniaFAERS: 4US FAERS
403ScreamingFAERS: 4US FAERS
404Sinus bradycardiaFAERS: 4US FAERS
405TenosynovitisFAERS: 4US FAERS
406Tongue bitingFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
407TrismusFAERS: 4US FAERS
408Vaginal DischargeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
409Ventricular arrhythmiaFAERS: 4US FAERS
410Vessel puncture site pruritusFAERS: 4US FAERS
411Vitreous DetachmentFAERS: 4US FAERS
412Vulvovaginal pruritusFAERS: 4US FAERS
413Accidental overdoseFAERS: 3US FAERS
414Activated partial thromboplastin time shortenedFAERS: 3US FAERS
415Acute psychosisFAERS: 3US FAERS
416Antithrombin III decreasedFAERS: 3US FAERS
417ApathyFAERS: 3US FAERS
418AsthenopiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
419AuraFAERS: 3US FAERS
420Autoimmune thyroiditisFAERS: 3US FAERS
421Bipolar I disorderFAERS: 3US FAERS
422Blood amylase increasedFAERS: 3US FAERS
423Blood blisterFAERS: 3US FAERS
424Blood creatine abnormalFAERS: 3US FAERS
425Blood creatine phosphokinase MB increasedFAERS: 3US FAERS
426Cardiac FlutterFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
427Cardiac enzymes increasedFAERS: 3US FAERS
428CholecystitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
429Chronic Fatigue SyndromeFAERS: 3US FAERS
430ClaustrophobiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
431ColectomyFAERS: 3US FAERS
432Corneal epithelium defectFAERS: 3US FAERS
433Coronary Artery DiseaseFAERS: 3US FAERS
434Dacryostenosis acquiredFAERS: 3US FAERS
435Deep Vein ThrombosisFAERS: 3US FAERS
436Deposit eyeFAERS: 3US FAERS
437Depression suicidalFAERS: 3US FAERS
438Diabetes mellitus inadequate controlFAERS: 3US FAERS
439DiverticulumFAERS: 3US FAERS
440DroolingFAERS: 3US FAERS
441Drug administered to patient of inappropriate ageFAERS: 3US FAERS
442Drug administration errorFAERS: 3US FAERS
443Drug dose omissionFAERS: 3US FAERS
444Drug withdrawal syndromeFAERS: 3US FAERS
445Ear congestionFAERS: 3US FAERS
446Electrocardiogram changeFAERS: 3US FAERS
447Emergency CareFAERS: 3US FAERS
448Erythema NodosumFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
449ExophthalmosFAERS: 3US FAERS
450Expired product administeredFAERS: 3US FAERS
451Food AllergyFAERS: 3US FAERS
452Foreign body traumaFAERS: 3US FAERS
453FractureFAERS: 3US FAERS
454Gait deviationFAERS: 3US FAERS
455Gait inabilityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
456Gastric DilatationFAERS: 3US FAERS
457Gastric infectionFAERS: 3US FAERS
458Guillain-Barre SyndromeFAERS: 3US FAERS
459Head titubationFAERS: 3US FAERS
460Heart sounds abnormalFAERS: 3US FAERS
461Hepatic necrosisFAERS: 3US FAERS
462ImmobileFAERS: 3US FAERS
463Inappropriate affectFAERS: 3US FAERS
464Incorrect dose administeredFAERS: 3US FAERS
465Infectious MononucleosisFAERS: 3US FAERS
466Infective exacerbation of chronic obstructive airways diseaseFAERS: 3US FAERS
467Injection site urticariaFAERS: 3US FAERS
468Intentional misuseFAERS: 3US FAERS
469Intestinal PerforationFAERS: 3US FAERS
470Iris vascular disorderFAERS: 3US FAERS
471Joint InstabilityFAERS: 3US FAERS
472Long QT SyndromeFAERS: 3US FAERS
473LymphangitisFAERS: 3US FAERS
474MegacolonFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
475Mucosal erosionFAERS: 3US FAERS
476Musculoskeletal chest painFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
477Myasthenic SyndromeFAERS: 3US FAERS
478Nasal discomfortFAERS: 3US FAERS
479Nephritis allergicFAERS: 3US FAERS
480NeuritisFAERS: 3US FAERS
481Nonspecific reactionFAERS: 3US FAERS
482Oral mucosal eruptionFAERS: 3US FAERS
483PeriarthritisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
484PertussisFAERS: 3US FAERS
485Product administration errorFAERS: 3US FAERS
486Product contamination physicalFAERS: 3US FAERS
487Productive CoughFAERS: 3US FAERS
488Pulmonary congestionFAERS: 3US FAERS
489QuadriplegiaFAERS: 3US FAERS
490Rehabilitation therapyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
491RhinitisFAERS: 3US FAERS
492SciaticaFAERS: 3US FAERS
493Skin lacerationFAERS: 3US FAERS
494SluggishnessFAERS: 3US FAERS
495TachyphreniaFAERS: 3US FAERS
496Temporal ArteritisFAERS: 3US FAERS
497TetanyFAERS: 3US FAERS
498Toxic anterior segment syndromeFAERS: 3US FAERS
499Transient psychosisFAERS: 3US FAERS
500Type III immune complex mediated reactionFAERS: 3US FAERS
501Vessel puncture site erythemaFAERS: 3US FAERS
502Visual acuity reduced transientlyFAERS: 3US FAERS
503Vulvovaginal mycotic infectionFAERS: 3US FAERS
504Walking aid userFAERS: 3US FAERS
505Wheelchair userFAERS: 3US FAERS
506effusionFAERS: 3US FAERS
507Acanthamoeba InfectionFAERS: 2US FAERS
508Acute Coronary SyndromeFAERS: 2US FAERS
509AlveolitisFAERS: 2US FAERS
510Amaurosis FugaxFAERS: 2US FAERS
511Ankle FractureFAERS: 2US FAERS
512Anoxic EncephalopathyFAERS: 2US FAERS
513Anti-thyroid antibody positiveFAERS: 2US FAERS
514AphoniaFAERS: 2US FAERS
515Apparent life threatening eventFAERS: 2US FAERS
516Application site irritationFAERS: 2US FAERS
517AtaxiaFAERS: 2US FAERS
518Atrial FlutterFAERS: 2US FAERS
519Autoimmune hepatitisFAERS: 2US FAERS
520Autonomic nervous system imbalanceFAERS: 2US FAERS
521Autonomic neuropathyFAERS: 2US FAERS
522Back disorderFAERS: 2US FAERS
523Bacterial culture positiveFAERS: 2US FAERS
524Blood bilirubin abnormalFAERS: 2US FAERS
525Blood cholesterol increasedFAERS: 2US FAERS
526Blood creatinine abnormalFAERS: 2US FAERS
527Blood magnesium decreasedFAERS: 2US FAERS
528Blood potassium increasedFAERS: 2US FAERS
529Blood urea increasedFAERS: 2US FAERS
530Brain AbscessFAERS: 2US FAERS
531Bronchial HyperreactivityFAERS: 2US FAERS
532BursitisFAERS: 2US FAERS
533CachexiaFAERS: 2US FAERS
534Cardiac DeathFAERS: 2US FAERS
535Cardiovascular insufficiencyFAERS: 2US FAERS
536Cartilage injuryFAERS: 2US FAERS
537Central nervous system lesionFAERS: 2US FAERS
538Cerebral disorderFAERS: 2US FAERS
539Cervix carcinoma recurrentFAERS: 2US FAERS
540ChokingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
541CholelithiasisFAERS: 2US FAERS
542Clostridium test positiveFAERS: 2US FAERS
543Complications of maternal exposure to therapeutic drugsFAERS: 2US FAERS
544Conversion disorderFAERS: 2US FAERS
545Coombs test positiveFAERS: 2US FAERS
546Corneal abscessFAERS: 2US FAERS
547Dermatitis acneiformFAERS: 2US FAERS
548Diabetic FootFAERS: 2US FAERS
549Disease recurrenceFAERS: 2US FAERS
550Dissociative disorderFAERS: 2US FAERS
551Drug ineffective for unapproved indicationFAERS: 2US FAERS
552Drug level increasedFAERS: 2US FAERS
553DysacusisFAERS: 2US FAERS
554EczemaFAERS: 2US FAERS
555Ejection Fraction DecreasedFAERS: 2US FAERS
556Electrolyte imbalanceFAERS: 2US FAERS
557Elevated moodFAERS: 2US FAERS
558EndocarditisFAERS: 2US FAERS
559Exposure during breast feedingFAERS: 2US FAERS
560Extraocular Muscle ParesisFAERS: 2US FAERS
561Extremity contractureFAERS: 2US FAERS
562Eye BurnsFAERS: 2US FAERS
563Eye allergyFAERS: 2US FAERS
564Eye ulcerFAERS: 2US FAERS
565Eyelid Function DisorderFAERS: 2US FAERS
566Facial paralysisFAERS: 2US FAERS
567Failure to ThriveFAERS: 2US FAERS
568Feeling of body temperature changeFAERS: 2US FAERS
569Flank PainFAERS: 2US FAERS
570Full blood count decreasedFAERS: 2US FAERS
571Fungal test positiveFAERS: 2US FAERS
572Gaze palsyFAERS: 2US FAERS
573General physical condition abnormalFAERS: 2US FAERS
574Genital burning sensationFAERS: 2US FAERS
575Genital rashFAERS: 2US FAERS
576Genital swellingFAERS: 2US FAERS
577HemiplegiaFAERS: 2US FAERS
578Hepatitis AFAERS: 2US FAERS
579HepatomegalyFAERS: 2US FAERS
580Hepatorenal SyndromeFAERS: 2US FAERS
581HungerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
582HyperpyrexiaFAERS: 2US FAERS
583HypothyroidismFAERS: 2US FAERS
584IleusFAERS: 2US FAERS
585Impaired gastric emptyingFAERS: 2US FAERS
586Inadequate analgesiaFAERS: 2US FAERS
587Inappropriate schedule of drug administrationFAERS: 2US FAERS
588Incorrect product storageFAERS: 2US FAERS
589Increased bronchial secretionFAERS: 2US FAERS
590Infusion site urticariaFAERS: 2US FAERS
591Infusion site vesiclesFAERS: 2US FAERS
592Injection related reactionFAERS: 2US FAERS
593Injection site painFAERS: 2US FAERS
594Injection site thrombosisFAERS: 2US FAERS
595Injection site vesiclesFAERS: 2US FAERS
596Intentional product misuseFAERS: 2US FAERS
597Intercepted medication errorFAERS: 2US FAERS
598Intervertebral Disc DegenerationFAERS: 2US FAERS
599Intestinal resectionFAERS: 2US FAERS
600Joint injuryFAERS: 2US FAERS
601Lactose IntoleranceFAERS: 2US FAERS
602Lid lagFAERS: 2US FAERS
603Liquid product physical issueFAERS: 2US FAERS
604Livedo ReticularisFAERS: 2US FAERS
605Liver transplant rejectionFAERS: 2US FAERS
606Loss of personal independence in daily activitiesFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
607Lower respiratory tract infectionFAERS: 2US FAERS
608Lung AbscessFAERS: 2US FAERS
609LymphomaFAERS: 2US FAERS
610MalabsorptionFAERS: 2US FAERS
611Malignant neoplasm progressionFAERS: 2US FAERS
612Markedly reduced dietary intakeFAERS: 2US FAERS
613Maternal exposure during pregnancyFAERS: 2US FAERS
614Meniscus injuryFAERS: 2US FAERS
615MeteoropathyFAERS: 2US FAERS
616Migraine with AuraFAERS: 2US FAERS
617Mitochondrial DNA mutationFAERS: 2US FAERS
618MultimorbidityFAERS: 2US FAERS
619NecrosisFAERS: 2US FAERS
620No adverse effectFAERS: 2US FAERS
621No reaction on previous exposure to drugFAERS: 2US FAERS
622NoduleFAERS: 2US FAERS
623Nuchal RigidityFAERS: 2US FAERS
624NystagmusFAERS: 2US FAERS
625Oculomucocutaneous syndromeFAERS: 2US FAERS
626OnychoclasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
627OphthalmoplegiaFAERS: 2US FAERS
628Optic AtrophyFAERS: 2US FAERS
629Optic NeuritisFAERS: 2US FAERS
630Optic NeuropathyFAERS: 2US FAERS
631OsteitisFAERS: 2US FAERS
632OsteoporosisFAERS: 2US FAERS
633ParaplegiaFAERS: 2US FAERS
634ParesisFAERS: 2US FAERS
635Pathogen resistanceFAERS: 2US FAERS
636Pelvic fluid collectionFAERS: 2US FAERS
637Personality ChangeFAERS: 2US FAERS
638PharyngitisFAERS: 2US FAERS
639Post procedural complicationFAERS: 2US FAERS
640PregnancyFAERS: 2US FAERS
641PresbyopiaFAERS: 2US FAERS
642Procalcitonin increasedFAERS: 2US FAERS
643ProteinuriaFAERS: 2US FAERS
644PurpuraFAERS: 2US FAERS
645PurulenceFAERS: 2US FAERS
646Pyoderma GangrenosumFAERS: 2US FAERS
647RadiculopathyFAERS: 2US FAERS
648Red man syndromeFAERS: 2US FAERS
649Rheumatic FeverFAERS: 2US FAERS
650ScabFAERS: 2US FAERS
651Sensation of blood flowFAERS: 2US FAERS
652Shock symptomFAERS: 2US FAERS
653Skin discomfortFAERS: 2US FAERS
654Skin hypertrophyFAERS: 2US FAERS
655Skin tightnessFAERS: 2US FAERS
656Sleep disorder due to general medical condition, insomnia typeFAERS: 2US FAERS
657SplenomegalyFAERS: 2US FAERS
658Staphylococcus test positiveFAERS: 2US FAERS
659SynovitisFAERS: 2US FAERS
660Systemic Inflammatory Response SyndromeFAERS: 2US FAERS
661Tension HeadacheFAERS: 2US FAERS
662Terminal stateFAERS: 2US FAERS
663Tongue pruritusFAERS: 2US FAERS
664VIIth nerve paralysisFAERS: 2US FAERS
665Vascular purpuraFAERS: 2US FAERS
666Venipuncture site swellingFAERS: 2US FAERS
667Violence-related symptomFAERS: 2US FAERS
668Winged scapulaFAERS: 2US FAERS
669Wrong drug administeredFAERS: 2US FAERS
670Wrong technique in product usage processFAERS: 2US FAERS
671Abdominal rigidityFAERS: 1US FAERS
672Abnormal weight gainFAERS: 1US FAERS
673AbscessFAERS: 1US FAERS
674Accidental exposure to productFAERS: 1US FAERS
675Acoustic NeuromaFAERS: 1US FAERS
676Acquired mitochondrial DNA mutationFAERS: 1US FAERS
677Adams-Stokes SyndromeFAERS: 1US FAERS
678AgnosiaFAERS: 1US FAERS
679AkinesiaFAERS: 1US FAERS
680Allergic keratitisFAERS: 1US FAERS
681Allergy to animalFAERS: 1US FAERS
682AmaurosisFAERS: 1US FAERS
683Anal FissureFAERS: 1US FAERS
684Anal discomfortFAERS: 1US FAERS
685Anal sphincter atonyFAERS: 1US FAERS
686Antimicrobial susceptibility test resistantFAERS: 1US FAERS
687Apallic syndromeFAERS: 1US FAERS
688Application site rashFAERS: 1US FAERS
689AscitesFAERS: 1US FAERS
690AtelectasisFAERS: 1US FAERS
691Avulsion fractureFAERS: 1US FAERS
692Bacteria stool identifiedFAERS: 1US FAERS
693Bacterial sepsisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
694Bilirubin conjugated increasedFAERS: 1US FAERS
695Bipolar DisorderFAERS: 1US FAERS
696Bladder painFAERS: 1US FAERS
697BlepharitisFAERS: 1US FAERS
698Blood albumin decreasedFAERS: 1US FAERS
699Blood chloride increasedFAERS: 1US FAERS
700Blood creatine increasedFAERS: 1US FAERS
701Blood glucose abnormalFAERS: 1US FAERS
702Blood glucose fluctuationFAERS: 1US FAERS
703Blood potassium abnormalFAERS: 1US FAERS
704Blood pressure inadequately controlledFAERS: 1US FAERS
705Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
706Blood triglycerides increasedFAERS: 1US FAERS
707Body TemperatureFAERS: 1US FAERS
708Body temperature fluctuationFAERS: 1US FAERS
709Bone density decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
710Bone marrow toxicityFAERS: 1US FAERS
711BradyphreniaFAERS: 1US FAERS
712Brain ContusionFAERS: 1US FAERS
713Breast infectionFAERS: 1US FAERS
714BronchiectasisFAERS: 1US FAERS
715BronchopneumoniaFAERS: 1US FAERS
716BruxismFAERS: 1US FAERS
717Carbon Monoxide PoisoningFAERS: 1US FAERS
718CardiomegalyFAERS: 1US FAERS
719CardiotoxicityFAERS: 1US FAERS
720Carotid pulse decreasedFAERS: 1US FAERS
721Catheter sepsisFAERS: 1US FAERS
722Cerebral cystFAERS: 1US FAERS
723Cervix carcinomaFAERS: 1US FAERS
724Chlamydia serology positiveFAERS: 1US FAERS
725ChoreoathetosisFAERS: 1US FAERS
726Chronic sinusitisFAERS: 1US FAERS
727Clostridium difficile infectionFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
728Clostridium difficile toxin test positiveFAERS: 1US FAERS
729ClumsinessFAERS: 1US FAERS
730Concomitant disease progressionFAERS: 1US FAERS
731Conjunctival depositFAERS: 1US FAERS
732Conjunctival ulcerFAERS: 1US FAERS
733Consciousness fluctuatingFAERS: 1US FAERS
734Cor pulmonaleFAERS: 1US FAERS
735Corneal InfectionFAERS: 1US FAERS
736Corneal PerforationFAERS: 1US FAERS
737Corneal ScarFAERS: 1US FAERS
738Corneal UlcerFAERS: 1US FAERS
739Corneal lesionFAERS: 1US FAERS
740Corneal thinningFAERS: 1US FAERS
741Cubital Tunnel SyndromeFAERS: 1US FAERS
742Cyclitic membraneFAERS: 1US FAERS
743CycloplegiaFAERS: 1US FAERS
744CystFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
745Delusional perceptionFAERS: 1US FAERS
746DermatomyositisFAERS: 1US FAERS
747Device malfunctionFAERS: 1US FAERS
748Diffuse lamellar keratitisFAERS: 1US FAERS
749Disease ProgressionFAERS: 1US FAERS
750Distributive shockFAERS: 1US FAERS
751DiverticulitisFAERS: 1US FAERS
752Dreamy stateFAERS: 1US FAERS
753Drug DependenceFAERS: 1US FAERS
754Drug label confusionFAERS: 1US FAERS
755Drug metabolising enzyme test abnormalFAERS: 1US FAERS
756Drug prescribing errorFAERS: 1US FAERS
757Drug resistanceFAERS: 1US FAERS
758DuodenitisFAERS: 1US FAERS
759DyscheziaFAERS: 1US FAERS
760DysphasiaFAERS: 1US FAERS
761EcchymosisFAERS: 1US FAERS
762Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
763Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
764Endodontic procedureFAERS: 1US FAERS
765Endotoxic shockFAERS: 1US FAERS
766Enlarged uvulaFAERS: 1US FAERS
767EnteritisFAERS: 1US FAERS
768Enterococcal infectionFAERS: 1US FAERS
769EnthesopathyFAERS: 1US FAERS
770Eosinophilic PneumoniaFAERS: 1US FAERS
771EpicondylitisFAERS: 1US FAERS
772ErythropeniaFAERS: 1US FAERS
773Eye operation complicationFAERS: 1US FAERS
774Eyelid margin crustingFAERS: 1US FAERS
775Eyelids pruritusFAERS: 1US FAERS
776Fine motor delayFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
777Fixed eruptionFAERS: 1US FAERS
778Food aversionFAERS: 1US FAERS
779FrustrationFAERS: 1US FAERS
780Full blood count abnormalFAERS: 1US FAERS
781Full blood count increasedFAERS: 1US FAERS
782Fungus culture positiveFAERS: 1US FAERS
783Gastric pH increasedFAERS: 1US FAERS
784Gastric ulcerFAERS: 1US FAERS
785Gastrointestinal inflammationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
786Gastrointestinal sounds abnormalFAERS: 1US FAERS
787Gingival RecessionFAERS: 1US FAERS
788GingivitisFAERS: 1US FAERS
789Gonioscopy abnormalFAERS: 1US FAERS
790Gum neoplasm malignant stage unspecifiedFAERS: 1US FAERS
791Hair injuryFAERS: 1US FAERS
792Hand-Arm Vibration SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
793Hearing disabilityFAERS: 1US FAERS
794Heat illnessFAERS: 1US FAERS
795HemiparesisFAERS: 1US FAERS
796Hepatic EncephalopathyFAERS: 1US FAERS
797HostilityFAERS: 1US FAERS
798HyperchlorhydriaFAERS: 1US FAERS
799HypohidrosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
800HysterectomyFAERS: 1US FAERS
801Idiosyncratic drug reactionFAERS: 1US FAERS
802Impaired quality of lifeFAERS: 1US FAERS
803ImpatienceFAERS: 1US FAERS
804Incision site complicationFAERS: 1US FAERS
805Incorrect drug administration durationFAERS: 1US FAERS
806Incorrect product administration durationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
807Incorrect route of drug administrationFAERS: 1US FAERS
808Infection in an immunocompromised hostFAERS: 1US FAERS
809Infective glossitisFAERS: 1US FAERS
810Infusion site hypersensitivityFAERS: 1US FAERS
811Infusion site painFAERS: 1US FAERS
812Inhibitory drug interactionFAERS: 1US FAERS
813Injection site phlebitisFAERS: 1US FAERS
814Instillation site painFAERS: 1US FAERS
815Instillation site scabFAERS: 1US FAERS
816Intellectual DisabilityFAERS: 1US FAERS
817Intentional drug misuseFAERS: 1US FAERS
818Intentional product use issueFAERS: 1US FAERS
819Intercepted drug administration errorFAERS: 1US FAERS
820IntubationFAERS: 1US FAERS
821Joint sprainFAERS: 1US FAERS
822Lack of spontaneous speechFAERS: 1US FAERS
823LaryngitisFAERS: 1US FAERS
824LaryngospasmFAERS: 1US FAERS
825Lead dislodgementFAERS: 1US FAERS
826Life expectancy shortenedFAERS: 1US FAERS
827Ligament injuryFAERS: 1US FAERS
828Ligament painFAERS: 1US FAERS
829Limb injuryFAERS: 1US FAERS
830Limb operationFAERS: 1US FAERS
831Lip pruritusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
832LividityFAERS: 1US FAERS
833Local reactionFAERS: 1US FAERS
834Lymphocyte count decreasedFAERS: 1US FAERS
835MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
836Macular degenerationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
837MaculeFAERS: 1US FAERS
838MalnutritionFAERS: 1US FAERS
839Maternal exposure before pregnancyFAERS: 1US FAERS
840MeaslesFAERS: 1US FAERS
841Mechanical urticariaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
842Medication residueFAERS: 1US FAERS
843Medication residue presentFAERS: 1US FAERS
844MeningismFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
845Meniscus operationFAERS: 1US FAERS
846MetastasisFAERS: 1US FAERS
847MetrorrhagiaFAERS: 1US FAERS
848MicroalbuminuriaFAERS: 1US FAERS
849Mitochondrial toxicityFAERS: 1US FAERS
850MonoparesisFAERS: 1US FAERS
851Morbid thoughtsFAERS: 1US FAERS
852Multi-organ disorderFAERS: 1US FAERS
853Multiple Chemical SensitivityFAERS: 1US FAERS
854Multiple allergiesFAERS: 1US FAERS
855Muscle FatigueFAERS: 1US FAERS
856Muscle SpasticityFAERS: 1US FAERS
857Muscular DystrophyFAERS: 1US FAERS
858MyocarditisFAERS: 1US FAERS
859Myoglobin blood increasedFAERS: 1US FAERS
860MyoglobinuriaFAERS: 1US FAERS
861MyopathyFAERS: 1US FAERS
862MyosclerosisFAERS: 1US FAERS
863Nasal PolypsFAERS: 1US FAERS
864Negative thoughtsFAERS: 1US FAERS
865NeurodermatitisFAERS: 1US FAERS
866NeuromaFAERS: 1US FAERS
867Nodular vasculitisFAERS: 1US FAERS
868Obsessive thoughtsFAERS: 1US FAERS
869Occult blood positiveFAERS: 1US FAERS
870Open woundFAERS: 1US FAERS
871OpisthotonusFAERS: 1US FAERS
872Oral mucosal exfoliationFAERS: 1US FAERS
873Orthosis userFAERS: 1US FAERS
874Orthostatic intoleranceFAERS: 1US FAERS
875OsteomyelitisFAERS: 1US FAERS
876Otitis ExternaFAERS: 1US FAERS
877Oxygen saturation abnormalFAERS: 1US FAERS
878PO2 decreasedFAERS: 1US FAERS
879Paranasal sinus discomfortFAERS: 1US FAERS
880Paranasal sinus hypersecretionFAERS: 1US FAERS
881ParaparesisFAERS: 1US FAERS
882Partner stressFAERS: 1US FAERS
883Patient uncooperativeFAERS: 1US FAERS
884Pelvic InfectionFAERS: 1US FAERS
885Penile blisterFAERS: 1US FAERS
886Pericardial effusionFAERS: 1US FAERS
887PericarditisFAERS: 1US FAERS
888Peripheral arterial occlusive diseaseFAERS: 1US FAERS
889Phantom painFAERS: 1US FAERS
890PhotokeratitisFAERS: 1US FAERS
891Plantar erythemaFAERS: 1US FAERS
892PneumothoraxFAERS: 1US FAERS
893PolydipsiaFAERS: 1US FAERS
894Poor quality product administeredFAERS: 1US FAERS
895Post-Traumatic Stress DisorderFAERS: 1US FAERS
896PosturingFAERS: 1US FAERS
897Poverty of speechFAERS: 1US FAERS
898Procedural complicationFAERS: 1US FAERS
899Procedural site reactionFAERS: 1US FAERS
900ProctitisFAERS: 1US FAERS
901ProctocolitisFAERS: 1US FAERS
902Product comminglingFAERS: 1US FAERS
903Product container issueFAERS: 1US FAERS
904Product counterfeitFAERS: 1US FAERS
905Product dispensing errorFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
906Product prescribing errorFAERS: 1US FAERS
907Product storage errorFAERS: 1US FAERS
908Product substitution issueFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
909Product use complaintFAERS: 1US FAERS
910ProstatismFAERS: 1US FAERS
911Protein urine presentFAERS: 1US FAERS
912Prothrombin level decreasedFAERS: 1US FAERS
913PsittacosisFAERS: 1US FAERS
914Pulmonary HypertensionFAERS: 1US FAERS
915Punctate keratitisFAERS: 1US FAERS
916Pupillary light reflex tests abnormalFAERS: 1US FAERS
917Purulent dischargeFAERS: 1US FAERS
918PyelonephritisFAERS: 1US FAERS
919Radial nerve palsyFAERS: 1US FAERS
920RalesFAERS: 1US FAERS
921Reaction to drug excipientsFAERS: 1US FAERS
922Rectal tenesmusFAERS: 1US FAERS
923Reduced facial expressionFAERS: 1US FAERS
924Refusal of treatment by relativeFAERS: 1US FAERS
925Relapsing FeverFAERS: 1US FAERS
926Renal cystFAERS: 1US FAERS
927Respiratory tract congestionFAERS: 1US FAERS
928Restrictive pulmonary diseaseFAERS: 1US FAERS
929Secretion dischargeFAERS: 1US FAERS
930Senile dementiaFAERS: 1US FAERS
931Serratia sepsisFAERS: 1US FAERS
932Sexual DysfunctionFAERS: 1US FAERS
933Shoulder PainFAERS: 1US FAERS
934Sjogren's SyndromeFAERS: 1US FAERS
935Skin ErosionFAERS: 1US FAERS
936Skin WrinklingFAERS: 1US FAERS
937Slow response to stimuliFAERS: 1US FAERS
938Slow speechFAERS: 1US FAERS
939Solar lentigoFAERS: 1US FAERS
940Somatic symptom disorderFAERS: 1US FAERS
941Somatoform DisorderFAERS: 1US FAERS
942Spinal column stenosisFAERS: 1US FAERS
943StaringFAERS: 1US FAERS
944Status EpilepticusFAERS: 1US FAERS
945Strawberry tongueFAERS: 1US FAERS
946Sudden Visual LossFAERS: 1US FAERS
947Superficial vein prominenceFAERS: 1US FAERS
948SymblepharonFAERS: 1US FAERS
949TachyarrhythmiaFAERS: 1US FAERS
950Tendon discomfortFAERS: 1US FAERS
951Therapy cessationFAERS: 1US FAERS
952Thoracic vertebral fractureFAERS: 1US FAERS
953ThyroiditisFAERS: 1US FAERS
954Tongue eruptionFAERS: 1US FAERS
955Tongue movement disturbanceFAERS: 1US FAERS
956Tonic clonic movementsFAERS: 1US FAERS
957Tooth ExtractionFAERS: 1US FAERS
958Tracheal StenosisFAERS: 1US FAERS
959TracheitisFAERS: 1US FAERS
960Transaminases decreasedFAERS: 1US FAERS
961Transcription medication errorFAERS: 1US FAERS
962Transfusion related complicationFAERS: 1US FAERS
963Traumatic Brain InjuryFAERS: 1US FAERS
964Trisomy 21FAERS: 1US FAERS
965UlcerFAERS: 1US FAERS
966Urinary hesitationFAERS: 1US FAERS
967Urine output increasedFAERS: 1US FAERS
968Urobilin urine presentFAERS: 1US FAERS
969Uterine ProlapseFAERS: 1US FAERS
970Vaginal mycosisFAERS: 1US FAERS
971Vagus Nerve DisorderFAERS: 1US FAERS
972Vagus nerve paralysisFAERS: 1US FAERS
973Vascular painFAERS: 1US FAERS
974Ventricular FlutterFAERS: 1US FAERS
975VerbigerationFAERS: 1US FAERS
976Vessel puncture site painFAERS: 1US FAERS
977Vitamin D DeficiencyFAERS: 1US FAERS
978Vitreous injuryFAERS: 1US FAERS
979Vocal Cord ParalysisFAERS: 1US FAERS
980pH body fluid abnormalFAERS: 1US FAERS
981prostatitisFAERS: 1US FAERS
982treatment failureFAERS: 1US FAERS
983Acute kidney injuryCanada Vigilance: 1Canada Vigilance
984Concomitant disease aggravatedCanada Vigilance: 1Canada Vigilance
985HyperkinesiaCanada Vigilance: 1Canada Vigilance
986Increased upper airway secretionCanada Vigilance: 1Canada Vigilance
987Mouth swellingCanada Vigilance: 1Canada Vigilance
988Pharyngeal swellingCanada Vigilance: 5Canada Vigilance
989Sinus painCanada Vigilance: 1Canada Vigilance
990Swelling of eyelidCanada Vigilance: 1Canada Vigilance
991Thrombocytopenic purpuraCanada Vigilance: 1Canada Vigilance
992Tongue discomfortCanada Vigilance: 2Canada Vigilance
993Upper respiratory tract congestionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.